ELI
OMCL icon

Empire Life Investments’s Omnicell OMCL Stock Holding History

Empire Life Investments’s Portfolio OMCL Stock Details OMCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-12,484
Closed -$469K – 110
2017
Q1 		$469K Buy
+12,484
New +$460K 0.05% 88

Other funds holding OMCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
DCM
Daruma Capital Management New York $879M AUM 2.11% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Empire Life Investments's OMCL Position: Q2 2017 in Review

Empire Life Investments sold out of Omnicell (OMCL) in Q2 2017, closing a stake of 12,484 shares — an estimated $469K sold.

Empire Life Investments first reported a position in OMCL in Q1 2017 and held it in 1 quarter. The position peaked at $469K in Q1 2017. 202 funds tracked by Wall St. Rank hold OMCL as of Q2 2017.

  • Empire Life Investments reported no remaining Omnicell position as of Q2 2017 after selling out during the quarter.
  • Empire Life Investments sold 12,484 Omnicell shares in Q2 2017, an estimated $469K.
  • Empire Life Investments first reported a position in Omnicell in Q1 2017 and held it in 1 quarter.
  • Empire Life Investments's Omnicell position peaked at $469K in Q1 2017.
  • 202 funds tracked by Wall St. Rank held Omnicell as of Q2 2017.

Based on Empire Life Investments's 13F filing for Q2 2017, filed 14 Aug 2017.